Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
This study is not yet open for participant recruitment.
Verified by Department of Veterans Affairs, May 2008
Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00688259
  Purpose

This is a study comparing the benefits of two types of individual psychotherapy (cognitive-behavioral therapy for psychosis and supportive therapy) in outpatients with schizophrenia or schizoaffective disorder. Treatmetn last 6 minths and ther are multiple assessment points.


Condition Intervention Phase
Schizophrenia
Schizoaffective Disorder
Other: supportive therapy
Other: cognitive-behaioral therapy for psychosis
Phase III

MedlinePlus related topics: Psychotic Disorders Schizophrenia
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Factorial Assignment, Efficacy Study
Official Title: Cognitive-Behavioral Therapy in Veterans With Schizophrenia

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • BPRS, SAS [ Time Frame: post-treatment and 3 month follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 122
Study Start Date: October 2008
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
approximately 20 sessions of individual manualized psychotherapy in which participants are taught to evaluate the data supporting beliefs that may interfere with recovery
Other: cognitive-behaioral therapy for psychosis
approximately 20 sessions of individual manualized psychotherapy in which participants are taught to evaluate the data supporting beliefs that may interfere with recovery
2: Active Comparator
approximately 20 sessions of manaulized psychotherapy to promote a strong alliance between the therapist and the participant in order to provide a safe place to discuss issues pertaining to recovery
Other: supportive therapy
approximately 20 sessions of manaulized psychotherapy to promote a strong alliance between the therapist and the participant in order to provide a safe palce to discuss issues pertaining to recovery

Detailed Description:

This is a randomized controlled trial comparing 6 months participation in one of two active treaments--cognitive-behavior therapy for psychosis and supportive therapy. Assessments of clinical status and social functioning will be obtained at baseline, mid-treatment, end of treatment, and 3 month follow-up. We hypothesize that participation in the cognitive-behaviorat therapy will lead to greater reductions in symptoms and improvements in social functioning.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

outpatients with schizophrenia or schizoaffectivd disorder in proximity to the west los angeles VAMC, at least one month since last hospitalization, stable antipsychotic medicaton for six months, persisting psychotic symptoms with at least minimal distress. competent to sign informed consent

Exclusion Criteria:

In other individual psychotherapy, presence of organic brain disease, mental retardation, or illness that would prohibit regular attendance in therapy. substance dependence diagnosis int he past 6 months,

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00688259

Contacts
Contact: Shirley M Glynn, PhD (310) 269-3939 sglynn@ucla.edu

Locations
United States, California
VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, United States, 90073
Sponsors and Collaborators
Investigators
Principal Investigator: Shirley M. Glynn, PhD VA Greater Los Angeles Healthcare System, West LA
  More Information

Responsible Party: Department of Veterans Affairs ( Glynn, Shirley - Principal Investigator )
Study ID Numbers: MHBB-016-07S
Study First Received: May 28, 2008
Last Updated: May 28, 2008
ClinicalTrials.gov Identifier: NCT00688259  
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
clinical trials
psychotherapy

Study placed in the following topic categories:
Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on January 16, 2009